AMA approves new CPT codes for Inspire V hypoglossal nerve stimulation system
The American Medical Association CPT Editorial Panel approved a set of Category I CPT codes that describe the implantation of Inspire Medical Systems' Inspire V hypoglossal nerve stimulation device. The codes will become effective on January 1, 2028. Inspire expects the new codes to simplify reimbursement, reduce administrative burden, and expand patient access, while CMS will determine Medicare payment values with proposed valuations in July 2027 and final valuations in November 2027.
Why it matters
The company says the dedicated codes should streamline coding and reimbursement, which could boost adoption of its therapy and support revenue growth. Investors may see a positive impact on Inspire's stock as the market priced the news with a 2.05% rise on the day of the announcement.
Key facts
- 1The AMA CPT Editorial Panel approved new Category I CPT codes for the Inspire V system. globenewswire.com
- 2The new CPT codes are scheduled to take effect on January 1, 2028. globenewswire.com
- 3CMS is expected to publish proposed reimbursement valuations in July 2027 and final valuations in November 2027. globenewswire.com
- 4Tim Herbert, Chairman and CEO of Inspire Medical Systems, said the codes will reduce administrative burden and support patient access. globenewswire.com
- 5INSP stock closed at $70.78, up 2.05%, on the day of the announcement. rttnews.com
Summary written by AlphAI from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.